RhePro

@rheproat.bsky.social

🤰🏻RHEumatic diseases and rePROduction ✨Science meets care Founded by Dr. A. Mazzucato-Puchner (Rheumatologist) & Ass.Prof. Dr. K. Rosta (OB/GYN) www.rhepro.at

Save the date for RheumaPreg 2025 Highlights Webinar! ⏰ Thanks to the inspiring leadership of the EULAR ReHFaP Study Group for making this possible.✨

Bild

RheumaPreg– It’s a wrap! A big thank you to all speakers, chairs and participants! We shared knowledge, sparked ideas, and built bridges between rheumatology and reproductive medicine.

Bild

Good morning from wonderful Vienna and our third day of #RheumaPreg2025! A day full of lively debates, patient perspectives, and important conversations around long-term challenges and gender inclusivity in reproductive rheumatology. Let’s dive in! 🤩

Bild

IMPACT Trial Certolizumab in high-risk pregnancies (APS + LAC): • Complications: ↓ from 80% to 20% • Gestational age: ↑ from 24 to 36.5 weeks • Live births: ↑ from 38% to 93% Huge congratulations to Jane Salmon & team – truly transformative results!

Bild

Day 2 of RheumaPreg 2025 is underway! Today’s sessions focus on clinical research in pregnancy, obstetric APS, neonatal lupus, immunosuppression during pregnancy, and hormonal influences in rheumatic diseases. Stay tuned for more insights and discussion.

Bild

RheumaPreg 2025 kicked off powerfully! We learned so much from experts in rheumatology and obstetrics – about fertility and the placenta. These insights are key to understanding pregnancy risks and improving care for women with rheumatic diseases. A strong beginning to an important conversation!

BildBild

RheumaPreg 2025 starts today in Vienna! From May 8–10, experts in rheumatology, immunology, and obstetrics will discuss pregnancy in rheumatic diseases, fertility, placental pathology, immune mechanisms, and clinical innovations. We look forward to an inspiring congress!

Bild